skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: American Society of Hematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A Genome-Wide Association Study (GWAS) Of Event-Free Survival In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Rituximab and Anthracycline-Based Chemotherapy: A Lysa and Iowa/Mayo Clinic SPORE Multistage Study
A Genome-Wide Association Study (GWAS) Of Event-Free Survival In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Rituximab and Anthracycline-Based Chemotherapy: A Lysa and Iowa/Mayo Clinic SPORE Multistage Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

A Genome-Wide Association Study (GWAS) Of Event-Free Survival In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Rituximab and Anthracycline-Based Chemotherapy: A Lysa and Iowa/Mayo Clinic SPORE Multistage Study

Ghesquieres, Herve ; Slager, Susan L ; Jardin, Fabrice ; Veron, Amelie S ; Novak, Anne ; Maurer, Matthew J ; Fest, Thierry ; Habermann, Thomas M ; Bene, Marie C ; Haioun, Corinne ; Lamy, Thierry ; Ansell, Stephen M ; Tilly, Herve ; Witzig, Thomas E ; Feldman, Andrew L. ; Dogan, Ahmet ; Cunningham, Julie M ; Olswold, Curtis L ; Asmann, Yan W ; Molina, Thierry Jo ; Link, Brian K ; Milpied, Noel ; Cox, David G ; Salles, Gilles Andre ; Cerhan, James R

Blood, 2013-11, Vol.122 (21), p.76-76 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
2
Activity of Idelalisib in High-Risk Follicular Lymphoma with Early Relapse Following Front Line Immunochemotherapy
Activity of Idelalisib in High-Risk Follicular Lymphoma with Early Relapse Following Front Line Immunochemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Activity of Idelalisib in High-Risk Follicular Lymphoma with Early Relapse Following Front Line Immunochemotherapy

Gopal, Ajay K ; Kahl, Brad S ; Flowers, Christopher ; Martin, Peter ; Link, Brian K ; Ansell, Stephen ; Ye, Wei ; Koh, Brian ; Abella, Steve ; Barr, Paul M. ; Salles, Gilles A. ; Friedberg, Jonathan W.

Blood, 2015-12, Vol.126 (23), p.2744-2744 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
3
Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies
Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies

Salles, G ; Zain, M ; Jiang, WM ; Boussiotis, VA ; Shipp, MA

Blood, 1993-12, Vol.82 (12), p.3539-3547 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
Alternatively Spliced CD44 Transcripts in Diffuse Large-Cell Lymphomas: Characterization and Comparison With Normal Activated B Cells and Epithelial Malignancies
Alternatively Spliced CD44 Transcripts in Diffuse Large-Cell Lymphomas: Characterization and Comparison With Normal Activated B Cells and Epithelial Malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Alternatively Spliced CD44 Transcripts in Diffuse Large-Cell Lymphomas: Characterization and Comparison With Normal Activated B Cells and Epithelial Malignancies

Salles, Gilles ; Zain, Mona ; Jiang, Wei-meng ; Boussiotis, Vassiliki A. ; Shipp, Margaret A.

Blood, 1993-12, Vol.82 (12), p.3539-3547 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier
Material Type:
Artigo 		Adicionar ao Meu Espaço

Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

Carpio, Cecilia ; Bouabdallah, Reda ; Ysebaert, Loïc ; Sancho, Juan-Manuel ; Salles, Gilles ; Cordoba, Raul ; Pinto, Antonio ; Gharibo, Mecide ; Rasco, Drew ; Panizo, Carlos ; Lopez-Martin, Jose A. ; Santoro, Armando ; Salar, Antonio ; Damian, Silvia ; Martin, Alejandro ; Verhoef, Gregor ; Van den Neste, Eric ; Wang, Maria ; Couto, Suzana ; Carrancio, Soraya ; Weng, Andrew ; Wang, Xuehai ; Schmitz, Frank ; Wei, Xin ; Hege, Kristen ; Trotter, Matthew W.B. ; Risueño, Alberto ; Buchholz, Tonia J. ; Hagner, Patrick R. ; Gandhi, Anita K. ; Pourdehnad, Michael ; Ribrag, Vincent

Blood, 2020-03, Vol.135 (13), p.996-1007 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
CD34(+) selection of autologous transplants following myeloablative therapy in patients with newly diagnosed myeloma shows no significant clinical benefit at 4 years: An EBMT phase III randomized study
CD34(+) selection of autologous transplants following myeloablative therapy in patients with newly diagnosed myeloma shows no significant clinical benefit at 4 years: An EBMT phase III randomized study
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

CD34(+) selection of autologous transplants following myeloablative therapy in patients with newly diagnosed myeloma shows no significant clinical benefit at 4 years: An EBMT phase III randomized study

Bourhis, JH ; Bouko, Y ; Koscielny, S ; Greinix, H ; Derigs, G ; Salles, G ; Feremans, W ; Bakkus, M ; Apperley, J ; Samson, D ; Gahrton, G ; Pico, JL ; Goldschmidt, H

BLOOD, 2003, Vol.102 (11), p.988A [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
CD34+selected PBPCT results in an increased infective risk without prolongation of event free survival in newly diagnosed myeloma: A randomised study from the EBMT
CD34+selected PBPCT results in an increased infective risk without prolongation of event free survival in newly diagnosed myeloma: A randomised study from the EBMT
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

CD34+selected PBPCT results in an increased infective risk without prolongation of event free survival in newly diagnosed myeloma: A randomised study from the EBMT

Goldschmidt, H ; Bouko, Y ; Bourhis, JH ; Greinix, H ; Salles, G ; Derigs, G ; Feremans, W ; Hegenbart, U ; Bakkus, M ; Samson, D ; Gahrton, G ; Pico, JL ; Apperley, J

BLOOD, 2000, Vol.96 (11), p.558A [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Deciphering the Clinical Benefit of Pola-R-CHP versus R-CHOP in Different Genetic Subtypes Beyond Cell of Origin in the POLARIX Study
Deciphering the Clinical Benefit of Pola-R-CHP versus R-CHOP in Different Genetic Subtypes Beyond Cell of Origin in the POLARIX Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Deciphering the Clinical Benefit of Pola-R-CHP versus R-CHOP in Different Genetic Subtypes Beyond Cell of Origin in the POLARIX Study

Morschhauser, Franck ; Leung, Wilfred ; Raghavan, Vibha ; Lenz, Georg ; Jardin, Fabrice ; Herrera, Alex F. ; Sehn, Laurie H. ; Sharman, Jeff P. ; Flowers, Christopher R. ; Friedberg, Jonathan W. ; Trněný, Marek ; Tilly, Hervé ; Herbaux, Charles ; Tracy, Samuel ; Bolen, Christopher R. ; Harris, Will ; Hirata, Jamie H. ; Lee, Calvin ; Jiang, Yanwen ; Salles, Gilles

Blood, 2023-11, Vol.142 (Supplement 1), p.3000-3000 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Effect of Age on the Efficacy and Safety of Single Agent Oral Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Pivotal Study
Effect of Age on the Efficacy and Safety of Single Agent Oral Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Pivotal Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of Age on the Efficacy and Safety of Single Agent Oral Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Pivotal Study

Schuster, Michael W. ; Canales, Miguel A ; Westin, Jason ; Zijlstra, Josée M ; Follows, George A ; Karmali, Reem ; Kalakonda, Nagesh ; Goy, Andre H. ; Casasnovas, Rene-Olivier ; Vermaat, Joost ; Van Den Neste, Eric ; Choquet, Sylvain ; Thieblemont, Catherine ; Cavallo, Federica ; De La Cruz, Maria de Fatima ; Hill, Brian T. ; Tilly, Herve ; Kassam, Shireen ; Bouabdallah, Reda ; Jaeger, Ulrich ; Gurion, Ronit ; Caimi, Paolo ; Martin, Peter ; Davies, Andrew ; Smith, Sonali M. ; Collins, Graham P. ; Offner, Fritz C. ; Salles, Gilles ; Ma, Xiwen ; Corona, Kelly ; Saint-Martin, Jean-Richard ; Joshi, Anita A. ; Chamoun, Kamal ; Wang, Hongwei ; Shah, Jatin J. ; Shacham, Sharon ; Kauffman, Michael G ; Maerevoet, Marie

Blood, 2020-11, Vol.136 (Supplement 1), p.5-6 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

Choquet, Sylvain ; Leblond, Veronique ; Herbrecht, Raoul ; Socié, Gérard ; Stoppa, Anne-Marie ; Vandenberghe, Peter ; Fischer, Alain ; Morschhauser, Franck ; Salles, Gilles ; Feremans, Walter ; Vilmer, Etienne ; Peraldi, Marie-Noelle ; Lang, Philippe ; Lebranchu, Yvon ; Oksenhendler, Eric ; Garnier, Jeanne Luce ; Lamy, Thierry ; Jaccard, Arnaud ; Ferrant, Augustin ; Offner, Fritz ; Hermine, Olivier ; Moreau, Anne ; Fafi-Kremer, Samira ; Morand, Patrice ; Chatenoud, Lucienne ; Berriot-Varoqueaux, Nathalie ; Bergougnoux, Loïc ; Milpied, Noel

Blood, 2006-04, Vol.107 (8), p.3053-3057 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.